(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
The Healthy on MSN1d
New Data: Nearly 50% of Weight-Loss Drug Patients Saw Lower Consumption of This, Too"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...
Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...
But between shortages, high out of pocket costs and the need for weekly injections, the medication is not suited for everyone ...
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...
Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback